Bodhi Tree Biotechnology Inc (BDTB) Operating Expenses (2024 - 2026)

Bodhi Tree Biotechnology (BDTB) has reported Operating Expenses for 3 consecutive years, with $33195.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 66.18% year-over-year to $33195.0 in Q2 2026; TTM through Jun 2026 was $128806.0, a N/A change from a year earlier, with the FY2025 full-year figure at $164618.0, up 69.79% from the prior year.
• Operating Expenses was $33195.0 for Q2 2026 at Bodhi Tree Biotechnology, down from $52949.0 in the prior quarter.
• Over five years, Operating Expenses peaked at $69777.0 in Q4 2024 and troughed at $19975.0 in Q2 2025.
• A 3-year average of $41793.7 and a median of $42687.0 in 2025 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses declined 24.12% in 2025 and jumped 66.18% in 2026, its largest moves.
• Over 3 years, Operating Expenses stood at $69777.0 in 2024, then retreated by 24.12% to $52949.0 in 2025, then plunged by 37.31% to $33195.0 in 2026.
• The last three Operating Expenses figures came in at $33195.0 (Q2 2026), $52949.0 (Q4 2025), and $22687.0 (Q3 2025), per Business Quant data.